aXichem AB Series A | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
376.00
-
-
-
Cost of Goods Sold (COGS) incl. D&A
3,324.30
5,907.00
-
-
-
Gross Income
3,324.30
5,531.00
-
-
-
SG&A Expense
-
-
7,716.00
5,923.00
7,134.00
EBIT
3,324.30
5,531.00
7,716.00
5,923.00
7,134.00
Non Operating Income/Expense
-
-
292.00
149.00
46.00
Interest Expense
336.00
113.00
-
-
195.00
Pretax Income
3,656.60
5,628.00
7,423.00
6,072.00
7,375.00
Consolidated Net Income
3,656.60
5,628.00
7,423.00
6,072.00
7,375.00
Net Income
3,656.60
5,628.00
7,423.00
6,072.00
7,375.00
Net Income After Extraordinaries
3,656.60
5,628.00
7,423.00
6,072.00
7,375.00
Net Income Available to Common
3,656.60
5,628.00
7,423.00
6,072.00
7,375.00
EPS (Basic)
0.46
0.71
0.83
0.61
0.50
Basic Shares Outstanding
7,876.00
7,907.50
8,943.20
9,884.70
14,806.70
EPS (Diluted)
0.46
0.71
0.83
0.61
0.50
Diluted Shares Outstanding
7,876.00
7,907.50
8,943.20
9,884.70
14,806.70
EBITDA
3,324.30
5,531.00
7,716.00
5,923.00
7,134.00
Non-Operating Interest Income
3.80
16.00
1.00
-
-

About aXichem AB

View Profile
Address
Vestre Torggaten 1
Bergen HL 5015
Norway
Employees -
Website http://www.axichem.se
Updated 09/14/2018
aXichem AB develops and sells natural-analogue industrial compounds. It offers bio-repellents, feed ingredients, and food and dietary supplements through its product, aXiphen an antifouling agent and analogue of natural capsaicin. The company was founded by Torsten Helsing in 1999 and is headquartered in Bergen, Norway.